| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |